We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Two national associations that oversee drug wholesale distributors have ratcheted up their requirements for membership and licensure to help in the battle against counterfeit pharmaceuticals.
New guidelines issued by the Health Industry Group Purchasing Association (HIGPA), which represents 175 healthcare purchasing and supply chain organizations, could help strengthen drugmakers’anticounterfeiting efforts.
Exercising for the first time its authority under the 1994 Dietary Supplement Health and Education Act (DSHEA), the FDA has banned dietary supplements containing ephedra because of safety concerns, the agency said when releasing the final rule. The ban takes effect April 12.